Furthermore, reversal of mitochondrial fragmentation by FUNDC2 knockdown reduces tumor energy level, reprograms cancer metabolism, and suppresses primary liver tumors in an MFN1-dependent manner in vivo. The gene discussed is FUNDC2; the disease is cancer.